These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37196701)

  • 21. Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action.
    Fonseca-Silva F; Inacio JD; Canto-Cavalheiro MM; Menna-Barreto RF; Almeida-Amaral EE
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004442. PubMed ID: 26862901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis.
    Wong IL; Chan KF; Chen YF; Lun ZR; Chan TH; Chow LM
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3379-88. PubMed ID: 24687505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
    Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine Susceptibility to
    Tomiotto-Pellissier F; Miranda-Sapla MM; Silva TF; Bortoleti BTDS; Gonçalves MD; Concato VM; Rodrigues ACJ; Detoni MB; Costa IN; Panis C; Conchon-Costa I; Bordignon J; Pavanelli WR
    Front Cell Infect Microbiol; 2021; 11():687633. PubMed ID: 34660334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
    Coelho AC; Trinconi CT; Costa CH; Uliana SR
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2999. PubMed ID: 25033218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
    Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR
    Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.
    Yamamoto ES; Campos BL; Laurenti MD; Lago JH; Grecco Sdos S; Corbett CE; Passero LF
    Parasitol Res; 2014 Jan; 113(1):333-9. PubMed ID: 24173812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
    Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
    J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis.
    Araujo VC; Fukutani KF; Oshiro ET; Rodrigues PO; Rizk YS; Carollo CA; Arruda CC
    Exp Parasitol; 2015 Oct; 157():138-44. PubMed ID: 26234915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice.
    Oliveira JC; da Silva AC; Oliveira RA; Pereira VR; Gil LH
    J Microbiol Methods; 2016 Nov; 130():189-195. PubMed ID: 27498229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.
    Trinconi CT; Reimão JQ; Coelho AC; Uliana SR
    J Antimicrob Chemother; 2016 May; 71(5):1314-22. PubMed ID: 26851606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Gonçalves GS; Fernandes AP; Souza RC; Cardoso JE; de Oliveira-Silva F; Maciel FC; Rabello A; Ferreira LA
    Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV; Fernandes AP; Ferreira LA
    Parasitol Res; 2007 May; 100(6):1221-6. PubMed ID: 17206508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
    Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
    Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
    Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
    Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
    da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
    J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.